Palatin Reports Second Quarter Fiscal Year 2022 Financial Re

CRANBURY, N.J., Feb. 15, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-cla...

Related Keywords

United States , American , Carl Spana , Fosun Pharma , Exchange Commission , Development Infrastructure , Palatin Technologies Inc , Securities Exchange , Colitis Congress , Palatin Technologies , Quarter Ended Fiscal Year , American Society , Retina Specialists , Hypoactive Sexual Desire Disorder , Fiscal Quarter Ended December , Termination Agreement , Melanocortin Receptor Agonists , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Financial Statement Data Follows , Months Ended December ,